Symphogen
Anette Aabo has a diverse work experience spanning multiple industries. Anette started their career in 1994 as an Accountant at Young & Rubicam, where they worked until 1999. Anette then moved on to DaimlerChrysler, where they served as a Sales Assistant until 2001. Anette then joined Eversheds, Denmark as an Accountant and worked there until 2005. Anette subsequently joined KCI Medical Aps as an Accountant, where they worked for a year before joining Symphogen in 2006. At Symphogen, Anette initially served as a Senior Accountant and later took on the role of Financial Controller starting in January 2023.
Anette Aabo's education history begins with their enrollment at Rødovre Statsskole, where they completed their high school education as an HF student in the year 1983. Following this, Anette attended Niels Brock, where they obtained a degree in Merkonom with a focus on Økonomi og resurcestyring. After a gap in their education, they later attended Copenhagen Business School from 2019 to 2021, where they pursued single courses in HD1, although the field of study for this program is not specified.
Symphogen
3 followers
Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities. Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.